- Risk Factors of Osteoporosis in Rheumatoid Arthritis Patients; Glucocorticoid, Inactivity, or Nutrient Deficiencies
-
Sung YK
- KMID: 2378083
- J Rheum Dis.
- 2017 Apr;24(2):63-64.
- doi: 10.4078/jrd.2017.24.2.63
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Add-on Clarithromycin and Tacrolimus Treatment for Rheumatoid Arthritis
-
Ohe M
- KMID: 2378092
- J Rheum Dis.
- 2017 Apr;24(2):123-124.
- doi: 10.4078/jrd.2017.24.2.123
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Radiotherapy, a New Treatment Option for Non-malignant Disorders: Radiobiological Mechanisms, Clinical Applications, and Radiation Risk
-
Park SH, Lee JE
- KMID: 2378085
- J Rheum Dis.
- 2017 Apr;24(2):74-84.
- doi: 10.4078/jrd.2017.24.2.74
Radiotherapy is used to treat not only malignant tumors but also benign inflammatory and hypertrophic diseases. Because of concerns about the potential hazards of irradiation, physicians in many countries, especially... -
- CITED
-
- Close
- SHARE
-
- Close
- Rivaroxaban for Thromboprophylaxis in Patients with Antiphospholipid Syndrome
-
Park JH, Song JS, Choi ST
- KMID: 2378089
- J Rheum Dis.
- 2017 Apr;24(2):108-113.
- doi: 10.4078/jrd.2017.24.2.108
The main treatment for Antiphospholipid syndrome (APS) is long-term anticoagulation with an oral vitamin K antagonist, although these are associated with numerous problems. Rivaroxaban is a direct anti-factor Xa inhibitor,... -
- CITED
-
- Close
- SHARE
-
- Close
- Does Painful Heels in Ankylosing Spondylitis Demonstrate Distinctive Features on Plain Radiographs: A Study of 104 Cases
-
Kim TH, Lee S, Sung IH, Kim SJ, Sung HK, Hur JS
- KMID: 2378087
- J Rheum Dis.
- 2017 Apr;24(2):93-98.
- doi: 10.4078/jrd.2017.24.2.93
OBJECTIVE: To investigate simple radiographic findings on painful heels in ankylosing spondylitis (AS). Heel radiography in most studies was from AS patients' non-painful heel. METHODS: Seventy AS patients (34 bilateral cases)... -
- CITED
-
- Close
- SHARE
-
- Close
- Aseptic Meningitis and Acute Kidney Injury after Immunoglobulin Infusion in a Patient with Systemic Lupus Erythematosus and Immune Thrombocytopenic Purpura
-
Jo S, Oh EH, Lee JY, Cho YK, Kwon OC, Ghang B, Kim YG
- KMID: 2378091
- J Rheum Dis.
- 2017 Apr;24(2):119-122.
- doi: 10.4078/jrd.2017.24.2.119
A 36-yr-old woman with systemic lupus erythematosus was admitted in our center because of thrombocytopenia that was being treated with corticosteroids. She was prescribed a four-day course of intravenous immunoglobulin... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary Arterial Hypertension is Normalized Following Six Years of Inhaled Iloprost Treatment in a Patient with Systemic Sclerosis
-
Yoon SY, Yoo ES, Yoo EJ, Jung JY, Kim HA, Suh CH
- KMID: 2378090
- J Rheum Dis.
- 2017 Apr;24(2):114-118.
- doi: 10.4078/jrd.2017.24.2.114
Pulmonary arterial hypertension is a critical manifestation of systemic sclerosis (SSc) and is a main cause of death. Several treatment modalities for SSc have been identified, with effects that improve... -
- CITED
-
- Close
- SHARE
-
- Close
- The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus
-
Stohl W
- KMID: 2378084
- J Rheum Dis.
- 2017 Apr;24(2):65-73.
- doi: 10.4078/jrd.2017.24.2.65
To review B-cell activating factor (BAFF)-antagonist therapy in systemic lupus erythematosus (SLE), literature was searched using the search words and phrases, “BAFFâ€, “B lymphocyte stimulator (BLyS)â€, “a proliferation-inducing ligand (APRIL)â€,... -
- CITED
-
- Close
- SHARE
-
- Close
- Meta-analysis of Circulating Adiponectin, Visfatin, and Ghrelin Levels in Patients with Systemic Lupus Erythematosus
-
Lee YH, Song GG
- KMID: 2378088
- J Rheum Dis.
- 2017 Apr;24(2):99-107.
- doi: 10.4078/jrd.2017.24.2.99
OBJECTIVE: To evaluate the association between circulating adiponectin, visfatin, and ghrelin levels and systemic lupus erythematosus (SLE). METHODS: We conducted a meta-analysis to compare serum/plasma adiponectin, visfatin, and ghrelin levels in... -
- CITED
-
- Close
- SHARE
-
- Close
- Urinary Tumor Necrosis Factor-like Weak Inducer of Apoptosis as a Biomarker for Lupus Nephritis: A Meta-analysis
-
Lee YH, Song GG
- KMID: 2378086
- J Rheum Dis.
- 2017 Apr;24(2):85-92.
- doi: 10.4078/jrd.2017.24.2.85
OBJECTIVE: This study evaluates serum or urinary tumor necrosis factor-like weak inducer of apoptosis (TWEAK) as a biomarker for lupus nephritis (LN). METHODS: We conducted a meta-analysis examining serum or urinary... -
- CITED
-
- Close
- SHARE
-
- Close
